This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In BioScrip, Inc. To Contact The Firm

NEW YORK, Oct. 11, 2013 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in BioScrip, Inc. ("BioScrip" or the "Company") (NASDAQ: BIOS) of the November 29, 2013 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against BioScrip and certain executives.

(Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO )

A complaint has been filed on behalf of all persons who purchased BioScrip securities between August 8, 2011 and September 20, 2013 (the "Class Period").

The complaint alleges that the Company and its executives violated federal securities laws with respect to its disclosures concerning its business, operations, and prospects.

Specifically, the action alleges that BioScrip issued false and/or misleading statements concerning (i) the improper distribution of its product Exjade through its specialty pharmacy division and (ii) the violation of certain federal and state laws and regulations.

On September 23, 2013, the Company announced that the U.S. Attorney's Office for the Southern District of New York issued a civil investigative demand and the New York State Attorney General's Medicaid Fraud Control Unit issued a subpoena regarding the distribution of Exjade by BioScrip's specialty pharmacy division. 

Following this news, the Company's stock declined $2.60 per share or 23% within two trading sessions, to close at $8.47 per share on September 24, 2013.

Request more information now by clicking here: www.faruqilaw.com/BIOS.  There is no cost or obligation to you.

Take Action

If you invested in BioScrip stock or options between August 8, 2011 and September 20, 2013 and would like to discuss your legal rights, visit www.faruqilaw.com/BIOS.  You can also contact us by calling Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com or fmcconville@faruqilaw.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding BioScrip's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com).  Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We welcome the opportunity to discuss your particular case.  All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP369 Lexington Avenue, 10th Floor New York, NY 10017Attn:  Richard Gonnello, Esq. rgonnello@faruqilaw.com Francis McConville, Esq. fmcconville@faruqilaw.comTelephone: (877) 247-4292 or (212) 983-9330

 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs